These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 21771230

  • 1. Graft fibrosis in patients with biliary atresia after pediatric living-related liver transplantation.
    Ueno T, Tanaka N, Ihara Y, Takama Y, Yamada H, Mushiake S, Fukuzawa M.
    Pediatr Transplant; 2011 Aug; 15(5):470-5. PubMed ID: 21771230
    [Abstract] [Full Text] [Related]

  • 2. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [Abstract] [Full Text] [Related]

  • 3. Impact of Donor-Specific Antibodies on Graft Fibrosis After Pediatric Living Donor Liver Transplantation for Biliary Atresia.
    Ueno T, Zenitani M, Yamanaka H, Tanaka N, Uehara S, Tazuke Y, Bessho K, Okuyama H.
    Transplant Proc; 2016 May; 48(4):1095-9. PubMed ID: 27320565
    [Abstract] [Full Text] [Related]

  • 4. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation.
    Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S.
    Transplantation; 2009 Feb 27; 87(4):606-14. PubMed ID: 19307800
    [Abstract] [Full Text] [Related]

  • 5. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.
    Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091
    [Abstract] [Full Text] [Related]

  • 6. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct 15; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 7. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients.
    Diem HV, Evrard V, Vinh HT, Sokal EM, Janssen M, Otte JB, Reding R.
    Transplantation; 2003 May 27; 75(10):1692-7. PubMed ID: 12777858
    [Abstract] [Full Text] [Related]

  • 8. Living donor liver transplantation for biliary atresia complicated by situs inversus: technical highlights.
    Matsubara K, Fujimoto Y, Kamei H, Ogawa K, Kasahara M, Ueda M, Egawa H, Takada Y, Kitajama M, Tanaka K.
    Liver Transpl; 2005 Nov 27; 11(11):1444-7. PubMed ID: 16237718
    [Abstract] [Full Text] [Related]

  • 9. Revisited impact of recipient age on the outcome of living donor liver transplantation for biliary atresia in the recent "transplantation era" in Japan.
    Ohya Y, Okajima H, Nishimori A, Lee KJ, Shirouzu Y, Yamamoto H, Takeichi T, Asonuma K, Inomata Y.
    Pediatr Transplant; 2009 Nov 27; 13(7):868-72. PubMed ID: 19207224
    [Abstract] [Full Text] [Related]

  • 10. Growth curves of pediatric patients with biliary atresia following living donor liver transplantation: factors that influence post-transplantation growth.
    Saito T, Mizuta K, Hishikawa S, Kawano Y, Sanada Y, Fujiwara T, Yasuda Y, Sugimoto K, Sakamoto K, Kawarasaki H.
    Pediatr Transplant; 2007 Nov 27; 11(7):764-70. PubMed ID: 17910654
    [Abstract] [Full Text] [Related]

  • 11. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 27; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for portal vein complications after pediatric living donor liver transplantation with left-sided grafts.
    Moon JI, Jung GO, Choi GS, Kim JM, Shin M, Kim EY, Kwon CH, Kim SJ, Joh JW, Lee SK.
    Transplant Proc; 2010 Apr 27; 42(3):871-5. PubMed ID: 20430193
    [Abstract] [Full Text] [Related]

  • 13. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM.
    Am J Surg Pathol; 2008 Jul 27; 32(7):965-73. PubMed ID: 18460980
    [Abstract] [Full Text] [Related]

  • 14. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
    Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, Minamiguchi S, Maekawa T, Uemoto S, Haga H.
    Liver Transpl; 2012 Nov 27; 18(11):1333-42. PubMed ID: 22888064
    [Abstract] [Full Text] [Related]

  • 15. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults.
    Kyoden Y, Tamura S, Sugawara Y, Yamashiki N, Matsui Y, Togashi J, Kaneko J, Kokudo N, Makuuchi M.
    Liver Transpl; 2008 Feb 27; 14(2):186-92. PubMed ID: 18236393
    [Abstract] [Full Text] [Related]

  • 16. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S, Dono K, Nagano H, Kim C, Asaoka T, Hama N, Kobayashi S, Takeda Y, Umeshita K, Monden M, Doki Y, Mori M.
    Clin Transplant; 2009 Feb 27; 23(6):904-13. PubMed ID: 19573088
    [Abstract] [Full Text] [Related]

  • 17. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, Iguchi T, Hashimoto N, Maehara Y.
    Transplantation; 2009 Aug 15; 88(3):303-7. PubMed ID: 19667930
    [Abstract] [Full Text] [Related]

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 19. The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis.
    Santos JL, Kieling CO, Meurer L, Vieira S, Ferreira CT, Lorentz A, Silveira TR.
    J Pediatr Surg; 2009 Apr 15; 44(4):695-701. PubMed ID: 19361628
    [Abstract] [Full Text] [Related]

  • 20. Incidence, impact, and treatment of portal and hepatic venous complications following pediatric liver transplantation: a single-center 12 year experience.
    Heffron TG, Pillen T, Smallwood G, Henry S, Sekar S, Casper K, Solis D, Tang W, Fasola C, Romero R.
    Pediatr Transplant; 2010 Sep 01; 14(6):722-9. PubMed ID: 20345612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.